Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single-Ascending Dose and Multiple-Ascending Dose Trial of Adjunctive EVX-101 in Healthy Volunteers Treated With a First-Line Antidepressant

– Putative therapeutic 5-HTP plasma exposures were achieved at all dose levels evaluated – Pharmacodynamic biomarker data demonstrated target engagement, indicative of brain extracellular serotonin elevation beyond the first-line antidepressant effect – The dose range was determined for the planned Phase 2 trial in Major Depressive Disorder patients inadequately responding to first-line antidepressant therapy RESEARCH … [Read more…]

Can-Fite: EMA Gives Green Light for Piclidenoson Pivotal Phase III Clinical Trial for Psoriasis Treatment

The Pivotal Study is Aimed to Support a Marketing Authorization Application PETACH TIKVA, Israel,–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that it received a positive opinion from the Committee for Medicinal Products for … [Read more…]

Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)

Aviceda is partnering with world-renowned scientist Professor Christopher Scott and his teams at the Patrick G. Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics. Aviceda Executives will participate in a Cancer Showcase Event as part of the 25th Anniversary of the Good Friday Agreement … [Read more…]

Henry Schein Medical Announces Winner of Its 2023 Rising Star Award Program

Recognition Honors Athletic Trainers for their Dedication Toward Advancing the Athletic Training Profession, While Keeping Athletes in the Game MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), announced Gina Harris, Head Athletic Trainer at Bellport High School in Brookhaven, New York, as the winner of the third annual … [Read more…]

NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023

SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results … [Read more…]

Axonics to Report First Quarter 2023 Financial Results on May 1

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to report first quarter 2023 financial results after the close of trading on Monday, May 1. Axonics will host a conference call at 4:30 p.m. Eastern Time … [Read more…]

United States Medical Device Outsourcing Market Report 2023: A $58.5 Billion Market by 2030 – Rise in Demand for High-tech Medical Devices and Stringent Regulations Bodes Well for Future Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis Report By Services (Quality Assurance, Contract Manufacturing), By Application (Cardiology, Diagnostic Imaging, IVD), By Class, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. medical device outsourcing market size is expected to reach USD 58.5 billion by … [Read more…]

Next-generation Sequencing Services Market Research Report 2023: A $24.5 Billion Market by 2030 – Decline In Sequencing Prices Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Next-generation Sequencing Services Market Size, Share & Trends Analysis Report By Service Type (Human Genome Sequencing, Gene Regulation Services), By Workflow, By End-use, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global next-generation sequencing services market size is expected to reach USD 24.5 billion by 2030 It … [Read more…]

Final Weeks to Register: 2 Day Pharmaceutical Regulatory Affairs in Asia Training Course – All Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (June 14-16, 2023) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in Asia Training Course” conference has been added to ResearchAndMarkets.com’s offering. This seminar will provide a practical overview of the key areas of pharmaceutical regulatory affairs in Asia, including India, and will cover all important aspects of gaining and maintaining a successful marketing authorisation within the region. The pharmaceutical market … [Read more…]

Syncell Showcases Pioneering Microscopy-Guided Subcellular Protein Scooping Technology at the AACR Annual Meeting 2023

TAIPEI, Taiwan & LOS ALTOS, Calif.–(BUSINESS WIRE)–Syncell, a biotech company pioneering in platforms for hypothesis-free spatial proteomics, will be exhibiting and presenting a poster at the AACR Annual Meeting 2023 in Orlando, FL. Syncell’s Microscoop technology enables microscopy-guided subcellular protein scooping in ultra-content powered by AI to collect enough proteins for subsequent spatial proteomic identification. … [Read more…]